Arfinn Med March Updates
We are very happy to announce the release of several new functions within the Arfinn Med Platform. Those include:
* Text message updates from patients regarding their treatments
* Templating for exam notes
* Updated analytics and dosing reports
* Google calendar and Calendly integrations to schedule appointments.
Please view the video below for more information and let our integration team show you how to seamlessly incorporate Arfinn Med into your practice!
Stories you may be interested in
Three Key Voices in the Medical Marijuana Industry
As medical marijuana programs continue to expand throughout the United States, it is important to recognize some of the key voices throughout the industry that got us here. These individuals range from researches to physicians and even to patients who started their own advocacy group. Keep reading to learn about just three of the many…
Read More 
What You Need to Know About CBD Oil
Cannabidiol (CBD) is a non-intoxicating extract from the hemp plant that is a natural remedy for many ailments like epilepsy, insomnia, nausea, anxiety and more. A popular method of taking CBD is in the form of an oil, which is made from pulling cannabidiol from the cannabis plant and diluting it with another oil. Once…
Read More 
$2.7 million awarded for medical marijuana research in Colorado
The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism. Read the full story here.
Read More 
More Treatment Options, Better Patient Outcomes
As more states start to pass medical marijuana legislation, patients benefit from having more options available to them regarding their treatment. In fact, a recent study from Columbia University’s Irving Medical Center found that, “States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana…
Read More 
Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease
A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More 
New Feature Updates
It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users. Those are the customizable consent and confirmation page…
Read More